Fortress Biotech repays remaining $15 million owed under Oaktree credit facility
The company settled the final balance on its senior secured loan on September 30, 2026, closing out an agreement first signed in 2024.
Fortress Biotech, Inc. disclosed in an 8-K filing that it repaid the remaining balance on its credit facility with Oaktree Fund Administration, LLC on September 30, 2026. The original agreement, a $50.0 million senior secured credit facility, was entered into on July 25, 2024, and had since been amended twice, first on December 12, 2025 and then on February 22, 2026.1
The September 30, 2026 payment covered $15.0 million in outstanding principal, plus roughly $435,000 in accrued interest, a $150,000 prepayment fee, and other closing costs.1
With the payment made, the company said the debt under the agreement was fully resolved and the lenders' security interests in Fortress Biotech's assets were released. All liens and other security interests in the Company's property tied to the Oaktree Agreement were released and terminated, and the agreement itself automatically terminated under its own terms.1
The filing was signed by Chief Financial Officer David Jin and dated October 1, 2026.
Written by readthrough’s AI from the linked primary sources and fact-checked against them automatically before publishing. Not investment advice.